No Data
No Data
Jefferies Maintains Viatris(VTRS.US) With Buy Rating, Maintains Target Price $15
Viatris Inc. (VTRS): A Strategic Shift in Healthcare Investments
Viatris Inc (VTRS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations
U.S. Government to Release Preliminary List for Pilot Medicare Program Offering Generics Under $2 - Report
Express News | Viatris Inc - No Serious Teaes Observed in Effexor Study
Express News | Viatris Inc - Pmda Submission for Effexor Targeted for 2025
Ape Power : KEN GRIFFIN COMMITTED FRAUD LIVE ON AIR! - AMC Stock Short Squeeze Update